Piwowarczyk-Nowak, A.; Pałasz, A.; Suszka-Świtek, A.; Błaszczyk, I.; Bogus, K.; Łasut-Szyszka, B.; Krzystanek, M.; Worthington, J.J.
Effect of Escitalopram on the Number of DCX-Positive Cells and NMUR2 Receptor Expression in the Rat Hippocampus under the Condition of NPSR Receptor Blockade. Pharmaceuticals 2022, 15, 631.
https://doi.org/10.3390/ph15050631
AMA Style
Piwowarczyk-Nowak A, Pałasz A, Suszka-Świtek A, Błaszczyk I, Bogus K, Łasut-Szyszka B, Krzystanek M, Worthington JJ.
Effect of Escitalopram on the Number of DCX-Positive Cells and NMUR2 Receptor Expression in the Rat Hippocampus under the Condition of NPSR Receptor Blockade. Pharmaceuticals. 2022; 15(5):631.
https://doi.org/10.3390/ph15050631
Chicago/Turabian Style
Piwowarczyk-Nowak, Aneta, Artur Pałasz, Aleksandra Suszka-Świtek, Iwona Błaszczyk, Katarzyna Bogus, Barbara Łasut-Szyszka, Marek Krzystanek, and John J. Worthington.
2022. "Effect of Escitalopram on the Number of DCX-Positive Cells and NMUR2 Receptor Expression in the Rat Hippocampus under the Condition of NPSR Receptor Blockade" Pharmaceuticals 15, no. 5: 631.
https://doi.org/10.3390/ph15050631
APA Style
Piwowarczyk-Nowak, A., Pałasz, A., Suszka-Świtek, A., Błaszczyk, I., Bogus, K., Łasut-Szyszka, B., Krzystanek, M., & Worthington, J. J.
(2022). Effect of Escitalopram on the Number of DCX-Positive Cells and NMUR2 Receptor Expression in the Rat Hippocampus under the Condition of NPSR Receptor Blockade. Pharmaceuticals, 15(5), 631.
https://doi.org/10.3390/ph15050631
